AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. HIMS
  4. [Form 4] Hims & Hers Health, Inc. Insider Trading Activity

[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Hims & Hers Health (HIMS) Chief Financial Officer Oluyemi Okupe executed a planned sale of 23,107 shares of Class A Common Stock on June 23, 2025, at an average weighted price of $47.2483 per share (range: $47.15 - $47.43).

Following the transaction, Okupe's holdings include:

  • 63,222 shares held directly
  • 70,575 shares held indirectly through the Oluyemi Okupe Separate Property Trust

The sale was conducted under a Rule 10b5-1 trading plan established on May 31, 2024, demonstrating pre-planned, compliant insider trading activity. This transaction represents a partial reduction of the CFO's direct holdings while maintaining significant equity stake in the company through both direct and trust ownership.

Oluyemi Okupe, Chief Financial Officer di Hims & Hers Health (HIMS), ha effettuato una vendita programmata di 23.107 azioni di Classe A Common Stock il 23 giugno 2025, a un prezzo medio ponderato di 47,2483$ per azione (range: 47,15$ - 47,43$).

Dopo la transazione, le partecipazioni di Okupe includono:

  • 63.222 azioni detenute direttamente
  • 70.575 azioni detenute indirettamente tramite l'Oluyemi Okupe Separate Property Trust

La vendita 猫 stata effettuata nell'ambito di un piano di trading conforme alla Regola 10b5-1, istituito il 31 maggio 2024, che dimostra un'attivit脿 di trading interna preprogrammata e conforme alle normative. Questa operazione rappresenta una riduzione parziale delle azioni detenute direttamente dal CFO, mantenendo comunque una significativa partecipazione azionaria nella societ脿 sia direttamente che tramite il trust.

Oluyemi Okupe, Director Financiero de Hims & Hers Health (HIMS), realiz贸 una venta planificada de 23,107 acciones de Clase A Common Stock el 23 de junio de 2025, a un precio promedio ponderado de $47.2483 por acci贸n (rango: $47.15 - $47.43).

Despu茅s de la transacci贸n, las participaciones de Okupe incluyen:

  • 63,222 acciones en propiedad directa
  • 70,575 acciones en propiedad indirecta a trav茅s del Oluyemi Okupe Separate Property Trust

La venta se realiz贸 bajo un plan de negociaci贸n conforme a la Regla 10b5-1 establecido el 31 de mayo de 2024, demostrando una actividad de negociaci贸n interna planificada y conforme. Esta transacci贸n representa una reducci贸n parcial de las acciones directas del CFO, manteniendo una participaci贸n significativa en la empresa tanto directa como a trav茅s del fideicomiso.

Hims & Hers Health (HIMS)鞚� 斓滉碃鞛毂呾瀯鞛�(CFO) Oluyemi Okupe電� 2025雲� 6鞗� 23鞚检棎 23,107欤�鞚� 韥措灅鞀� A 氤错喌欤茧ゼ 欤茧嫻 韽夑窢 臧�欷戧皜瓴� $47.2483 (氩旍渼: $47.15 - $47.43)鞐� 瓿勴殟鞝侅溂搿� 毵る弰頃橃榾鞀惦媹雼�.

瓯半灅 頉� Okupe鞚� 氤挫湢 欤检嫕鞚� 雼れ潓瓿� 臧欖姷雼堧嫟:

  • 歆侅爲 氤挫湢頃� 63,222欤�
  • Oluyemi Okupe Separate Property Trust毳� 韱淀暅 臧勳爲 氤挫湢 70,575欤�

鞚措矆 毵る弰電� 2024雲� 5鞗� 31鞚检棎 靹れ爼霅� Rule 10b5-1 瓯半灅 瓿勴殟鞐� 霐半澕 鞚措（鞏挫鞙茧┌, 靷爠鞐� 瓿勴殟霅� 攴滌爼 欷�靾� 雮措秬鞛� 瓯半灅鞛勳潉 氤挫棳欷嶋媹雼�. 鞚� 瓯半灅電� CFO鞚� 歆侅爲 氤挫湢 欤检嫕鞚� 鞚茧秬 欷勳澑 瓴冹澊歆�毵�, 歆侅爲 氚� 鞁犿儊 氤挫湢毳� 韱淀暣 須岇偓鞐� 雽�頃� 靸侂嫻頃� 歆�攵勳潉 鞙犾頃橁碃 鞛堨姷雼堧嫟.

Oluyemi Okupe, Directeur Financier de Hims & Hers Health (HIMS), a r茅alis茅 une vente planifi茅e de 23 107 actions de Classe A Common Stock le 23 juin 2025, 脿 un prix moyen pond茅r茅 de 47,2483 $ par action (plage : 47,15 $ - 47,43 $).

Apr猫s la transaction, les avoirs d'Okupe comprennent :

  • 63 222 actions d茅tenues directement
  • 70 575 actions d茅tenues indirectement via le Oluyemi Okupe Separate Property Trust

La vente a 茅t茅 r茅alis茅e dans le cadre d'un plan de trading conforme 脿 la r猫gle 10b5-1 茅tabli le 31 mai 2024, d茅montrant une activit茅 d'initi茅 pr茅-planifi茅e et conforme. Cette transaction repr茅sente une r茅duction partielle des avoirs directs du CFO tout en maintenant une participation significative dans la soci茅t茅, 脿 la fois directement et via le trust.

Oluyemi Okupe, Chief Financial Officer von Hims & Hers Health (HIMS), f眉hrte am 23. Juni 2025 einen geplanten Verkauf von 23.107 Aktien der Klasse A Stammaktien zu einem durchschnittlichen gewichteten Preis von 47,2483 $ pro Aktie (Spanne: 47,15 $ - 47,43 $) durch.

Nach der Transaktion umfasst Okupe's Beteiligungen:

  • 63.222 Aktien direkt gehalten
  • 70.575 Aktien indirekt 眉ber den Oluyemi Okupe Separate Property Trust gehalten

Der Verkauf erfolgte im Rahmen eines Rule 10b5-1 Handelsplans, der am 31. Mai 2024 eingerichtet wurde, und zeigt eine vorab geplante, regelkonforme Insider-Transaktion. Diese Transaktion stellt eine teilweise Reduzierung der direkten Beteiligungen des CFO dar, w盲hrend weiterhin eine bedeutende Aktienposition im Unternehmen sowohl direkt als auch 眉ber den Trust gehalten wird.

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Oluyemi Okupe, Chief Financial Officer di Hims & Hers Health (HIMS), ha effettuato una vendita programmata di 23.107 azioni di Classe A Common Stock il 23 giugno 2025, a un prezzo medio ponderato di 47,2483$ per azione (range: 47,15$ - 47,43$).

Dopo la transazione, le partecipazioni di Okupe includono:

  • 63.222 azioni detenute direttamente
  • 70.575 azioni detenute indirettamente tramite l'Oluyemi Okupe Separate Property Trust

La vendita 猫 stata effettuata nell'ambito di un piano di trading conforme alla Regola 10b5-1, istituito il 31 maggio 2024, che dimostra un'attivit脿 di trading interna preprogrammata e conforme alle normative. Questa operazione rappresenta una riduzione parziale delle azioni detenute direttamente dal CFO, mantenendo comunque una significativa partecipazione azionaria nella societ脿 sia direttamente che tramite il trust.

Oluyemi Okupe, Director Financiero de Hims & Hers Health (HIMS), realiz贸 una venta planificada de 23,107 acciones de Clase A Common Stock el 23 de junio de 2025, a un precio promedio ponderado de $47.2483 por acci贸n (rango: $47.15 - $47.43).

Despu茅s de la transacci贸n, las participaciones de Okupe incluyen:

  • 63,222 acciones en propiedad directa
  • 70,575 acciones en propiedad indirecta a trav茅s del Oluyemi Okupe Separate Property Trust

La venta se realiz贸 bajo un plan de negociaci贸n conforme a la Regla 10b5-1 establecido el 31 de mayo de 2024, demostrando una actividad de negociaci贸n interna planificada y conforme. Esta transacci贸n representa una reducci贸n parcial de las acciones directas del CFO, manteniendo una participaci贸n significativa en la empresa tanto directa como a trav茅s del fideicomiso.

Hims & Hers Health (HIMS)鞚� 斓滉碃鞛毂呾瀯鞛�(CFO) Oluyemi Okupe電� 2025雲� 6鞗� 23鞚检棎 23,107欤�鞚� 韥措灅鞀� A 氤错喌欤茧ゼ 欤茧嫻 韽夑窢 臧�欷戧皜瓴� $47.2483 (氩旍渼: $47.15 - $47.43)鞐� 瓿勴殟鞝侅溂搿� 毵る弰頃橃榾鞀惦媹雼�.

瓯半灅 頉� Okupe鞚� 氤挫湢 欤检嫕鞚� 雼れ潓瓿� 臧欖姷雼堧嫟:

  • 歆侅爲 氤挫湢頃� 63,222欤�
  • Oluyemi Okupe Separate Property Trust毳� 韱淀暅 臧勳爲 氤挫湢 70,575欤�

鞚措矆 毵る弰電� 2024雲� 5鞗� 31鞚检棎 靹れ爼霅� Rule 10b5-1 瓯半灅 瓿勴殟鞐� 霐半澕 鞚措（鞏挫鞙茧┌, 靷爠鞐� 瓿勴殟霅� 攴滌爼 欷�靾� 雮措秬鞛� 瓯半灅鞛勳潉 氤挫棳欷嶋媹雼�. 鞚� 瓯半灅電� CFO鞚� 歆侅爲 氤挫湢 欤检嫕鞚� 鞚茧秬 欷勳澑 瓴冹澊歆�毵�, 歆侅爲 氚� 鞁犿儊 氤挫湢毳� 韱淀暣 須岇偓鞐� 雽�頃� 靸侂嫻頃� 歆�攵勳潉 鞙犾頃橁碃 鞛堨姷雼堧嫟.

Oluyemi Okupe, Directeur Financier de Hims & Hers Health (HIMS), a r茅alis茅 une vente planifi茅e de 23 107 actions de Classe A Common Stock le 23 juin 2025, 脿 un prix moyen pond茅r茅 de 47,2483 $ par action (plage : 47,15 $ - 47,43 $).

Apr猫s la transaction, les avoirs d'Okupe comprennent :

  • 63 222 actions d茅tenues directement
  • 70 575 actions d茅tenues indirectement via le Oluyemi Okupe Separate Property Trust

La vente a 茅t茅 r茅alis茅e dans le cadre d'un plan de trading conforme 脿 la r猫gle 10b5-1 茅tabli le 31 mai 2024, d茅montrant une activit茅 d'initi茅 pr茅-planifi茅e et conforme. Cette transaction repr茅sente une r茅duction partielle des avoirs directs du CFO tout en maintenant une participation significative dans la soci茅t茅, 脿 la fois directement et via le trust.

Oluyemi Okupe, Chief Financial Officer von Hims & Hers Health (HIMS), f眉hrte am 23. Juni 2025 einen geplanten Verkauf von 23.107 Aktien der Klasse A Stammaktien zu einem durchschnittlichen gewichteten Preis von 47,2483 $ pro Aktie (Spanne: 47,15 $ - 47,43 $) durch.

Nach der Transaktion umfasst Okupe's Beteiligungen:

  • 63.222 Aktien direkt gehalten
  • 70.575 Aktien indirekt 眉ber den Oluyemi Okupe Separate Property Trust gehalten

Der Verkauf erfolgte im Rahmen eines Rule 10b5-1 Handelsplans, der am 31. Mai 2024 eingerichtet wurde, und zeigt eine vorab geplante, regelkonforme Insider-Transaktion. Diese Transaktion stellt eine teilweise Reduzierung der direkten Beteiligungen des CFO dar, w盲hrend weiterhin eine bedeutende Aktienposition im Unternehmen sowohl direkt als auch 眉ber den Trust gehalten wird.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Okupe Oluyemi
(Last) (First) (Middle)
2269 CHESTNUT STREET, #523
(Street)
SAN FRANCISCO CA 94123
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 06/23/2025 S(1) 23,107 D $47.2483(2) 63,222 D
Class A Common Stock 70,575 I Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.
2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $47.15 - $47.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Remarks:
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact 06/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many HIMS shares did CFO Oluyemi Okupe sell on June 23, 2025?

CFO Oluyemi Okupe sold 23,107 shares of HIMS Class A Common Stock on June 23, 2025 at an average weighted price of $47.2483 per share.

What is the total HIMS stock ownership of CFO Oluyemi Okupe after the June 2025 transaction?

After the transaction, CFO Oluyemi Okupe owned a total of 133,797 shares of HIMS, consisting of 63,222 shares held directly and 70,575 shares held indirectly through the Oluyemi Okupe Separate Property Trust dated 9-1-2021.

Was HIMS CFO Okupe's stock sale part of a pre-planned trading arrangement?

Yes, the sales were executed pursuant to a Rule 10b5-1 trading plan that was adopted by CFO Okupe on May 31, 2024, approximately one year before the transaction.

What was the price range of HIMS shares sold by CFO Okupe in the June 2025 transaction?

The HIMS shares were sold at varying prices ranging from $47.15 to $47.43 per share, with a weighted average price of $47.2483.
Stock HIMS logo
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

#1499 Ranked by Market Cap
N/A Ranked by Dividends

HIMS Latest News

Jul 9, 2025
Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion
Jun 3, 2025
Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
May 22, 2025
Hims & Hers Introduces 6-Month Wegovy庐 New Customer Offer
May 8, 2025
Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
May 8, 2025
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare

HIMS Latest SEC Filings

Jul 8, 2025
[144] Hims & Hers Health, Inc. SEC Filing
Jul 8, 2025
[Form 4] Hims & Hers Health, Inc. Insider Trading Activity
Jul 1, 2025
[Form 4] Hims & Hers Health, Inc. Insider Trading Activity
Jun 30, 2025
[144] Hims & Hers Health, Inc. SEC Filing
Jun 23, 2025
[144] Hims & Hers Health, Inc. SEC Filing

HIMS Stock Data

10.62B
190.62M
11.25%
79.06%
23.34%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
United States
SAN FRANCISCO